Phase IIA Study of the HDAC Inhibitor ITF2357 in Patients With JAK-2 V617F Positive Chronic Myeloproliferative Diseases

Clinical trial NCT00606307 · COMPLETED

Trial details

NCT number: NCT00606307
Sponsor: Italfarmaco
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myeloproliferative Diseases

Start date: 2007-12-01
Primary completion: 2008-12-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.